Ethic Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Ethic Inc.

$5.46 Billion
Q2 2025

A detailed history of Ethic Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ethic Inc. holds 16,847 shares of REGN stock, worth $9.38 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

16,847

Previous 7,081 137.92%

Holding current value

$9.38 Million

Previous $4.49 Million 96.97%

% of portfolio

0.16%

Previous 0.09%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 30, 2025	BUY	$483.07 - $625.6 $4.72 Million - $6.11 Million	9,766 Added 137.92%	16,847 $8.84 Million
Q1 2025 May 13, 2025	SELL	$634.14 - $744.83 $2.27 Million - $2.67 Million	-3,587 Reduced 33.62%	7,081 $4.49 Million
Q4 2024 Feb 14, 2025	BUY	$701.85 - $1046.91 $3.16 Million - $4.72 Million	4,509 Added 73.21%	10,668 $7.6 Million
Q3 2024 Nov 13, 2024	SELL	$1024.09 - $1201.76 $290,841 - $341,299	-284 Reduced 4.41%	6,159 $6.47 Million
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $250,828 - $304,217	284 Added 4.61%	6,443 $6.77 Million
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $543,419 - $597,996	602 Added 10.83%	6,159 $5.93 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $202,321 - $230,123	-261 Reduced 4.49%	5,557 $4.88 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $122,563 - $149,453	177 Added 3.14%	5,818 $4.79 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $42,001 - $49,821	60 Added 1.08%	5,641 $4.05 Million
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $1.55 Million - $1.88 Million	2,271 Added 68.61%	5,581 $4.59 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $618,359 - $671,357	876 Added 35.99%	3,310 $2.39 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $21,236 - $26,799	-37 Reduced 1.5%	2,434 $1.68 Million
Q2 2022 Aug 10, 2022	BUY	$548.35 - $738.84 $297,205 - $400,451	542 Added 28.1%	2,471 $1.46 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $240,428 - $282,165	404 Added 26.49%	1,929 $1.35 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $71,739 - $88,568	132 Added 9.48%	1,525 $963,000
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $203,780 - $241,740	355 Added 34.2%	1,393 $843,000
Q2 2021 Aug 10, 2021	BUY	$472.8 - $558.54 $137,112 - $161,976	290 Added 38.77%	1,038 $580,000
Q1 2021 May 13, 2021	SELL	$446.73 - $548.2 $53,160 - $65,235	-119 Reduced 13.73%	748 $354,000
Q4 2020 Feb 10, 2021	BUY	$478.3 - $607.98 $21,523 - $27,359	45 Added 5.47%	867 $419,000
Q3 2020 Oct 27, 2020	BUY	$544.75 - $658.21 $120,389 - $145,464	221 Added 36.77%	822 $460,000
Q2 2020 Aug 12, 2020	BUY	$493.32 - $643.92 $64,131 - $83,709	130 Added 27.6%	601 $375,000
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $158,340 - $232,876	471 New	471 $230,000

Others Institutions Holding REGN

# of Institutions

1,398

Shares Held

85.3M

Call Options Held

1.39M

Put Options Held

1.42M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $59.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.

Account